BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11688965)

  • 41. Localization of low-KM cAMP phosphodiesterase in rat nephron segments.
    Yoshida I; Takeda S; Homma S; Kusano E; Asano Y
    Kidney Blood Press Res; 1997; 20(5):307-11. PubMed ID: 9419046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Occupancy of the catalytic site of the PDE4A4 cyclic AMP phosphodiesterase by rolipram triggers the dynamic redistribution of this specific isoform in living cells through a cyclic AMP independent process.
    Terry R; Cheung YF; Praestegaard M; Baillie GS; Huston E; Gall I; Adams DR; Houslay MD
    Cell Signal; 2003 Oct; 15(10):955-71. PubMed ID: 12873709
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
    Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
    Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Type IV phosphodiesterase activity specifically regulates cAMP-stimulated casein secretion in the rat mammary gland.
    Pooley L
    Biochim Biophys Acta; 2002 Jun; 1590(1-3):84-92. PubMed ID: 12063171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relaxation of guinea-pig trachea by cyclic AMP phosphodiesterase inhibitors and their enhancement by sodium nitroprusside.
    Turner NC; Lamb J; Worby A; Murray KJ
    Br J Pharmacol; 1994 Apr; 111(4):1047-52. PubMed ID: 8032589
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Release of cAMP gating by the alpha6beta4 integrin stimulates lamellae formation and the chemotactic migration of invasive carcinoma cells.
    O'Connor KL; Shaw LM; Mercurio AM
    J Cell Biol; 1998 Dec; 143(6):1749-60. PubMed ID: 9852165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).
    Thompson WJ; Ashikaga T; Kelly JJ; Liu L; Zhu B; Vemavarapu L; Strada SJ
    Biochem Pharmacol; 2002 Feb; 63(4):797-807. PubMed ID: 11992650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of rolipram, pimobendan and zaprinast on ischaemia-induced dysrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat.
    Carceles MD; Aleixandre F; Fuente T; López-Vidal J; Laorden ML
    Eur J Anaesthesiol; 2003 Mar; 20(3):205-11. PubMed ID: 12650491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
    Bivalacqua TJ; Champion HC; Rajasekaran M; Sikka SC; Kadowitz PJ; Doherty PC; Hellstrom WJ
    J Urol; 1999 Nov; 162(5):1848-55. PubMed ID: 10524946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of adenosine 3',5'-cyclic monophosphate (cAMP) accumulation in UMR-106 osteoblast-like cells: role of cAMP-phosphodiesterase and cAMP efflux.
    Ahlström M; Lamberg-Allardt C
    Biochem Pharmacol; 1999 Oct; 58(8):1335-40. PubMed ID: 10487537
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phosphodiesterase 4 inhibition synergizes with relaxin signaling to promote decidualization of human endometrial stromal cells.
    Bartsch O; Bartlick B; Ivell R
    J Clin Endocrinol Metab; 2004 Jan; 89(1):324-34. PubMed ID: 14715868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term hormonal regulation of the cAMP-specific phosphodiesterases in cultured FRTL-5 thyroid cells.
    Takahashi SI; Nedachi T; Fukushima T; Umesaki K; Ito Y; Hakuno F; Van Wyk JJ; Conti M
    Biochim Biophys Acta; 2001 Jul; 1540(1):68-81. PubMed ID: 11476896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition by reproterol of cAMP PDE in intact mastocytoma P-815 cells.
    Alvarez-Guerra M; Libertus H; Garay RP
    Pulm Pharmacol Ther; 2004; 17(4):213-8. PubMed ID: 15219266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine.
    Podzuweit T; Nennstiel P; Müller A
    Cell Signal; 1995 Sep; 7(7):733-8. PubMed ID: 8519602
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task.
    Giorgi M; Modica A; Pompili A; Pacitti C; Gasbarri A
    Behav Brain Res; 2004 Sep; 154(1):99-106. PubMed ID: 15302115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY; Loh HH
    Mol Pharmacol; 1993 May; 43(5):684-93. PubMed ID: 8388986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Properties and hormonal regulation of two structurally related cAMP phosphodiesterases from the rat Sertoli cell.
    Swinnen JV; Tsikalas KE; Conti M
    J Biol Chem; 1991 Sep; 266(27):18370-7. PubMed ID: 1655746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
    Sutor B; Mantell K; Bacher B
    Neurosci Lett; 1998 Aug; 252(1):57-60. PubMed ID: 9756358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined effects of insulin and dexamethasone on cyclic AMP phosphodiesterase 3 and glycogen metabolism in cultured rat hepatocytes.
    Hermsdorf T; Dettmer D
    Cell Signal; 1998 Oct; 10(9):629-35. PubMed ID: 9794244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.